Akebia Therapeutics (NASDAQ:AKBA) executives outlined the company’s near- and mid-term priorities at the Leerink Partners Global Healthcare Conference, emphasizing the commercialization of its anemia ...

San Francisco-based Anthropic is challenging a decision by the department and other federal agencies to shift their AI work to other providers, based on a risk designation typically reserved for ...